|
Recalibration of cognitive prognostic model
|
|
12
|
692
|
August 28, 2024
|
|
Andersen-Gill - multistate and time varying covariate
|
|
6
|
619
|
August 27, 2024
|
|
Individual response
|
|
247
|
42408
|
August 21, 2024
|
|
Good reading on when "doubly robust" is worth the effort?
|
|
4
|
930
|
August 18, 2024
|
|
HMisc::transcan() vs FMIL missing data technique
|
|
1
|
362
|
August 17, 2024
|
|
Summary table of different Cox PHM models to compare them
|
|
3
|
415
|
August 12, 2024
|
|
Euphemystical randomization
|
|
0
|
361
|
August 12, 2024
|
|
Hmisc::transcan() vs FIML
|
|
3
|
478
|
August 11, 2024
|
|
RMS Multivariable Modeling Strategies
|
|
67
|
30171
|
August 10, 2024
|
|
C-index with clustered data
|
|
1
|
499
|
August 8, 2024
|
|
Meta-analysis of calibration slopes
|
|
4
|
3334
|
August 7, 2024
|
|
Time for a change in language: statistical divergence and the 95% non-divergent interval (95%nDI)
|
|
32
|
3373
|
August 5, 2024
|
|
Bayesian Proportion Odds with repeated measures
|
|
8
|
912
|
August 5, 2024
|
|
Help needed interpreting a regression table from a logistic model
|
|
2
|
570
|
August 4, 2024
|
|
First-order Markov model suitability for different time points
|
|
1
|
434
|
August 2, 2024
|
|
Recalibration of prognostic model
|
|
1
|
459
|
August 2, 2024
|
|
How do we mistake biological plausibility for clinical relevance?
|
|
18
|
1568
|
August 1, 2024
|
|
Where are the exceptional responders?
|
|
2
|
434
|
July 31, 2024
|
|
What do you think of the state of surrogate endpoint validation in chronic kidney disease?
|
|
6
|
541
|
July 31, 2024
|
|
Modelling correlated and longitudinal complex dataset with mice
|
|
2
|
485
|
July 28, 2024
|
|
Appropriate statistical test for trend analysis (AI models and statisticians experinece)
|
|
0
|
597
|
July 27, 2024
|
|
Marginal Structural Models
|
|
2
|
464
|
July 25, 2024
|
|
In search of the right methodology to analyze the outcome of repeat hospitalizations
|
|
1
|
569
|
July 25, 2024
|
|
Project 2025 and Biostatisticians
|
|
0
|
405
|
July 25, 2024
|
|
Effect sizes for power and evidence for effectiveness
|
|
24
|
1540
|
July 24, 2024
|
|
Power and sample size planning with canonical correlation analysis
|
|
3
|
460
|
July 23, 2024
|
|
Use of percentage change in clinical trials
|
|
17
|
5042
|
July 22, 2024
|
|
Evaluating seizures in open-label studies
|
|
8
|
849
|
July 21, 2024
|
|
Plain language in published papers and specialist correspondence
|
|
0
|
449
|
July 21, 2024
|
|
Should I Use Regularization in Univariate Logistic Regression for Diagnostic Methods Comparison?
|
|
3
|
565
|
July 19, 2024
|